Skip to main content
. 2020 Apr;80(4):454–461. doi: 10.1016/j.jinf.2020.01.015

Fig. 3.

Fig. 3

Upper panels show age-specific anti-Pgp3 seroprevalence in children aged 1–9 years in (A) Vanuatu (n = 1084) and (B) Tarawa, Kiribati (n = 1015). Lower panels show age-specific anti-Pgp3 seroprevalence in people of all ages in (C) Vanuatu (n = 3401) and (D) Tarawa, Kiribati (n = 2805). Samples collected June–September 2016. Red whiskers indicate 95% confidence intervals.